RecruitingPhase 1Phase 2NCT02350205

SASS 2 : Self Assembled Skin Substitute for the Autologous Treatment of Severe Burn Wounds in Acute Stage of Burn Trauma

SASS 2 : Self Assembled Skin Substitute for the Autologous Treatment of Severe Burn Wounds in Acute Stage of Burn Trauma.

Sponsor

CHU de Quebec-Universite Laval

Enrollment

52 participants

Start Date

Dec 1, 2015

Study Type

INTERVENTIONAL

Conditions

Burns

Summary

This clinical trial is designed to assess the safety, effectiveness and benefits of Self Assembled Skin Substitute SASS grafts as a permanent skin replacement for the treatment of full-thickness burn wounds that require permanent coverage where the availability of donor sites is limited.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called Self assembled skin substitute (SASS) for people with burns. The study is currently recruiting participants at 7 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALSelf assembled skin substitute (SASS)

All patients in Phase B will receive Self assembled skin substitute (SASS)

Locations(8)

Foothill Medcial Centre

Calgary, Alberta, Canada

Mackenzie Health Science's Centre

Edmonton, Alberta, Canada

Vancouver General Hospital

Vancouver, British Columbia, Canada

BC Children's Hospital Plastic Surgery Clinic

Vancouver, British Columbia, Canada

Winnipeg Health Science Center

Winnipeg, Manitoba, Canada

Hospital for Sick Children (Sickkids)

Toronto, Ontario, Canada

Hôpital Sainte Justine

Montreal, Quebec, Canada

CHU de Québec - Unité des grands brûlés

Québec, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02350205

Related Trials

Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft

NCT063797241 location

A Prospective Study Using SupraSDRM® in Promoting Healing and Reducing the Time to Grafting of Full-thickness Wounds

NCT06503406

Phase III Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents

NCT067455571 location

Autologous Point-of-Care Adipose Therapy: Recent Injury

NCT068574482 locations

Autologous Point-of-Care Adipose Therapy: Delayed Injury/Scar

NCT068574352 locations